Starter Panel
A focused first look at mold-related biomarkers
The Starter Health Panel is a lower-friction way to begin body-side screening when mold exposure is plausible but the full picture is still forming.
Listed price
$56 listed
Method
LabCorp blood draw
Results
Typically 2-3 weeks after collection
Availability
Available in most U.S. states except NY, NJ, HI, and RI in the current catalog.
Best fit
Use this test when it can answer the right question.
MoldCo keeps the test lane explicit so a home question, body question, and susceptibility question do not get collapsed into one claim.
People who want the lowest-cost body-side screen.
Patients with symptoms and exposure history who are not ready for a broader panel.
Readers who need objective data beyond routine labs.
What it measures
- TGF-beta1, an inflammatory cytokine.
- MMP-9, a marker associated with immune and inflammatory activity.
- MSH, a hormone-regulation marker often discussed in mold-related illness care.
What it cannot prove
- A full CIRS workup.
- Home mold detection.
- A yes/no mold toxicity answer without symptoms and history.
How it works
From order to interpretation
Order the panel through the app.
Receive a LabCorp requisition.
Complete the blood draw at LabCorp.
Use results as one input in a broader mold-related illness review.
Before you order
These answers keep the clinical boundary clear: useful context, not a standalone diagnosis.
Why only three markers?
These markers give an accessible first look at inflammatory, immune, and hormone-regulation signals that MoldCo providers often interpret in mold-related illness context.
Can I take this before starting care?
Yes. Some people use it as a first screen. If symptoms are severe, complex, or persistent, provider-guided care may be the more useful starting point.
Not sure this is the right next step?
Take the Mold Risk Score first, or start care and let a provider help decide whether testing is useful.